Lansoprazol Generis (Lansoprazole)

Lansoprazole irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, in the parietal cells of the stomach. This blocks the final step of acid secretion, resulting in a sustained decrease in gastric acidity and allowing damaged mucosa to heal.

The prescribed dose of lansoprazole is determined by the treating clinician based on the specific indication, patient age, renal function, and treatment duration. Typical adult regimens range from once‑daily to twice‑daily dosing, but exact instructions must come from a qualified healthcare professional.

Safety data for lansoprazole during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lansoprazole belongs to the same class as omeprazole, esomeprazole, pantoprazole and rabeprazole. All PPIs share a similar mechanism of reducing gastric acid, but differences exist in pharmacokinetics, drug‑interaction profiles, and dosing convenience. Lansoprazole is often chosen for its rapid onset and well‑documented efficacy in ulcer healing.

Store the tablets at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep out of reach of children and do not use the product after the expiry date printed on the packaging.

Lansoprazol Generis is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, most commonly before breakfast, unless the prescriber advises otherwise.

Serious risks, though uncommon, include Clostridioides difficile‑associated colitis, severe hypomagnesemia, interstitial nephritis, and an increased risk of bone fractures with long‑term use. Patients should report persistent diarrhea, muscle weakness, unexplained bruising, or severe abdominal pain to their healthcare provider promptly.

Individuals with known hypersensitivity to lansoprazole, other proton pump inhibitors, or any component of the formulation should avoid the product. Caution is also advised for patients with severe liver impairment, and it should not be used in conjunction with certain drugs such as clopidogrel without medical supervision.